ArticleCureus2025
Pemphigus Foliaceus in a Patient With Pre-existing Atopic Dermatitis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pemphigus foliaceus (PF) is a rare autoimmune blistering skin disease characterized by superficial erosions and crusts due to autoantibodies targeting desmoglein 1. Diagnosis can be challenging, particularly when initial presentation mimics common dermatoses such as atopic dermatitis. We report the case of a 55-year-old Syrian female initially diagnosed with severe atopic dermatitis, who presented with widespread pruritic skin lesions unresponsive to corticosteroids. Clinical deterioration with new vesiculobullous lesions prompted re-evaluation. Histopathology and serologic testing confirmed PF. The patient achieved disease control with systemic corticosteroids and immunosuppressive therapy and remains in remission after two years of follow-up. This case underscores the diagnostic complexity of PF, especially in patients with overlapping or misleading dermatologic histories. A high index of suspicion, timely biopsy, and serological confirmation are essential for diagnosis. Long-term immunosuppressive therapy combined with corticosteroids proved effective in achieving sustained remission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.